[Familial myoclonus-dystonia syndrome associated with panic attacks].
We report a case of autosomal dominantly inherited dystonia and panic attacks to discuss successful treatment of a common serotonergic pathology with medication. The objective analysis of the movement disorder was done by Optotrak. First we demonstrate a reduction of the myoclonus by L-5-hydroxytryptophan, which inhibits after 11 months. After changing the medication to Nefadozone, the myoclonus and the frequency of panic attacks were reduced.
Scheidtmann
K
K
Neurologische Klinik Bad Aibling. Kscheidtmann@Schoen-Kliniken.de
Müller
F
F
Hartmann
E
E
Koenig
E
E
D000328:Adult; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D020821:Dystonic Disorders / Q000188:drug therapy / Q000235:genetics*; D005260:Female; D005799:Genes, Dominant / Q000235:genetics; D006801:Humans; D009207:Myoclonus / Q000188:drug therapy / Q000235:genetics*; D016584:Panic Disorder / Q000188:drug therapy / Q000235:genetics*; D010375:Pedigree; D010879:Piperazines; D013577:Syndrome; D014230:Triazoles / Q000008:administration & dosage
D010879:Piperazines; D014230:Triazoles; C051752:nefazodone